A Study of SH009 Injection in Patients With Advanced Solid Tumors.
05 Feb 20264 min read0 viewsINTERVENTIONAL Trial
GIST (Key Takeaways)
RECRUITING · INTERVENTIONAL · TREATMENT study · Liver Cancer (Locally Advanced or Metastatic) · Phase 1 · Enrollment 150 · Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd.
Clinical Editorial
ClinicalTrials.gov published a clinical update in Oncology on 05 Feb 2026. The item focuses on A Study of SH009 Injection in Patients With Advanced Solid Tumors. Open the detail page to review the full original feed content.
Source Reference
Read the full original publication from the source journal or publisher link below.